5-Bromopyridine-2-carboxylic acid → HCID 71252936, compound
Reaction equation
[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]([OH:10])=O)=[N:6][CH:7]=1.[CH2:11]([C:13]1[CH:14]=[C:15]([CH3:25])[C:16]([N:19]2[CH2:24][CH2:23][NH:22][CH2:21][CH2:20]2)=[N:17][CH:18]=1)[CH3:12]>>[Br:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]([N:22]2[CH2:23][CH2:24][N:19]([C:16]3[C:15]([CH3:25])=[CH:14][C:13]([CH2:11][CH3:12])=[CH:18][N:17]=3)[CH2:20][CH2:21]2)=[O:10])=[N:6][CH:7]=1Participants
3
Procedure
Using 5-bromo-2-picolinic acid (206 mg) and 1-(5-ethyl-3-methylpyridin-2-yl)piperazine (220 mg) described in Preparation Example 81 and by the reaction and treatment in the same manner as in Preparation Example 109, the title compound (170 mg) was obtained.
Workup
- customdescribed in Preparation Example 81 and by the reaction and treatment in the same manner as in Preparation Example 109
Sources & evidence
- ORD record
- ord-5c8cc4b171b54998b951eed6d25fc6d4
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…